Emerging Topic Conference – Reproductive Health in Liver Disease

This OnDemand conference, Reproductive Health in Liver Disease, will apply knowledge from the growing contemporary literature to dispel pre-existing myths surrounding reproductive health in chronic liver disease. Updated data will be presented in the context of sexual dysfunction and reproductive counseling in chronic liver disease, as well as risk stratification of pregnancy and management recommendations for patients with chronic liver disease from pre-conception through delivery. 

When & Where

Date: Friday, July 22 2022, 8:00 am - Tuesday, January 31 2023, 11:59 pm (EST)
Location: OnDemand Conference
Continuing Education Credits: CME ABIM MOC

Program Chairs

  • Maria D. Hernandez, MD
  • Monika Sarkar, MD
  • Kidist K. Yimam, MD

NEW Conference Format 

The OnDemand conference will have pre-recorded presentations from the experts along with a discussion forum to ask questions of the faculty. Additional supplemental materials will be available on the conference platform.

Continuing Education

CME Hours: 4.50 AMA PRA Category 1 Credits™
ABIM MOC Points: 4.50 ABIM MOC Points

Registration Pricing

  • Member: $210
  • NonMember: $290
  • Associate Member: $150
  • Associate NonMember: $230
  • Student Member: $75
  • Student NonMember: $115
  • Trainee Member: $150
  • Trainee NonMember: $230
  • Industry: $700
  • Patient Advocates: $25
  • Patients & Caregivers: $25 

Registration scholarships are available by request for the Patient Advocates and Patients Caregivers categories. Please contact Michael Providence at mprovidence@aasld.org for further details.

Requests for cancellations must be submitted in writing to meetings@aasld.org.

Cancellations received by Friday, July 8, 2022 will be refunded in full.

Cancellations received between July 9 –  July 21, 2022 will be subject to a $50.00 cancellation fee.

Cancellations received on or after July 22, 2022 are not eligible for a refund.

Continuing Education

Continuing Medical Education (CME): 4.50 AMA PRA Category 1 Credits

ABIM Maintenance of Certification (MOC): 4.50 ABIM MOC Points

Continuing Medical Education (CME) 
The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.  Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity.  It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

CME Credits

Physicians and other health care professionals seeking AMA PRA Category 1 Credits™ for this OnDemand continuing medical education activity must complete an evaluation by Tuesday, January 30, 2023. The CME evaluation will be available to you upon presentation viewing completion on the conference platform.

MOC Points

Physicians seeking ABIM MOC points must complete the CME and MOC evaluation by Tuesday, January 30, 2023.  Requests for MOC after this date will not be honored.  The MOC evaluation is included in the CME evaluation.

MOC Points will be reported to the ABIM by the end of the month for attendees who successfully complete the MOC evaluation.

The conference, Reproductive Health in Liver Disease, will apply knowledge from the growing contemporary literature to dispel pre-existing myths surrounding reproductive health in chronic liver disease. Updated data will be presented in the context of sexual dysfunction and reproductive counseling in chronic liver disease, as well as risk stratification of pregnancy and management recommendations for patients with chronic liver disease from pre-conception through delivery. 

Upon completion of this activity, learners will be able to:

  • Manage major categories of chronic liver disease in pregnancies, risk stratify cirrhotic patients seeking pregnancy and manage portal hypertensive complications in pregnancy
  • Provide reproductive counseling in pre- and post-LT male and female patients and discuss safety of contraceptives in the context of various liver conditions
  • Understand safety of modalities of imaging in pregnancy and lactation and determine when a biopsy would be indicated.

  • Hepatologists
  • Gastroenterologists
  • Nurse Practitioners
  • Pharmacists
  • Physician Assistants
  • Transplant Coordinators
  • Surgeons
  • Fellows/Trainees
  • Internal and Family Medicine Providers
  • Obstetricians and Gynecologists

Agenda

Session I: Sexual Function, Sexual Activity and Fertility Considerations in Male and Female Patients With Liver Disease

  • Sexual Health in Adolescents: Introducing Transitions in Care and Patient Scaffold
    Jean P. Molleston, MD
  • Sexual Dysfunction in Men and Women with Liver Disease: Where We Fall Short 
    Patrizia Burra, MD, PhD, FAASLD
  • Updates in Contraception Management: Where the AASLD and CDC Diverge 
    Sara Whetstone, MD
  • Fertility Treatment in Liver Disease
    Vandana Khungar, MD, MSc

Session II: Reproductive Health Considerations With Chronic Liver Disease

  • Understanding Hormones and Liver Disease: Menopause, Andropause, and Transgender Health 
    Carla W. Brady, MD, MHS, FAASLD
  • Hepatitis C in Pregnancy- Time for Third Trimester Treatment?  
    Norah Terrault, MD, MPH, FAASLD
  • Intrahepatic Cholestasis: Rethinking the Role of Ursodiol
    Cynthia Levy, MD, FAASLD
  • Reproductive Health and NAFLD: Enter PCOS and Pregnancy
    Monika Sarkar, MD, MAS

Session III: Diagnostic Testing and Pharmacology Safety in Pregnancy

  • Approach to Liver Tests in Pregnancy- What’s Normal, What’s Not
    Jaquelyn F. Fleckenstein, MD, FACP, FAASLD
  • Imaging (Including Elastography) and Biopsy in Pregnancy and Lactation  
    Erica Villa, MD
  • Safety of Common Liver-Related Medications in Pregnancy and Lactation: The Move from FDA Categories to Individualized Approach
    Tatyana Kushner, MD, MSCE

Session IV: Cirrhosis and Liver Lesions in Pregnancy- Pre-Conception Through Delivery

  • Evolving Epidemiology and Prognostic Scoring for Cirrhosis in Pregnancy 
    Jennifer A. Flemming, MD
  • Variceal Screening and Management- The Changing Landscape of Risk 
    Maria D. Hernandez, MD
  • Hepatic Adenomas and Pregnancy: What We’ve Learned from the PALM Study 
    Jennifer E. Guy, MD, MAS

Session V: Reproductive Potpourri

  • Time to Step-Up: The Role of Transplant Providers in Pre-Conception Counseling
    Monika Sarkar, MD, MAS
  • Transplant Med Management in Men and Women Starting Families: Dispelling Myths with Registry Data
    Lisa Coscia, RN, BSN, CCTC
  • Conducting Liver Research in Pregnancy: Advice from the Obstetric Lens
    Yalda Afshar, MD, PhD
  • Case Presentations: Management Dilemmas in Pregnancy
    Kidist Yimam, MD. Panelists: Michele M. Tana, MD and Michael A. Heneghan, MD, MMedSc, FRCPI